{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:12:31Z","timestamp":1761534751736,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":3050,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1111\/jth.12590","type":"journal-article","created":{"date-parts":[[2014,4,26]],"date-time":"2014-04-26T05:32:50Z","timestamp":1398490370000},"page":"1193-1195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Warfarin or dabigatran for treatment of atrial fibrillation"],"prefix":"10.1016","volume":"12","author":[{"given":"L.","family":"Poller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12590_bb0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1538-7836.2008.02959.x","article-title":"An international multicentre study of computer assisted oral anticoagulant dosage versus medical staff","volume":"6","author":"Poller","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12590_bb0015","first-page":"64","article-title":"Guidelines for thromboplastin and plasmas used to control oral anticoagulant therapy","volume":"889","author":"van den Besselaar","year":"1999","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1111\/jth.12590_bb0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12590_bb0025","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1373\/clinchem.2009.141937","article-title":"Simplified method for international normalised ratio (INR) derivation based on the prothrombin time\/INR Line. An International Study","volume":"56","author":"Poller","year":"2010","journal-title":"Clin Chem"},{"key":"10.1111\/jth.12590_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1538-7836.2010.04109.x","article-title":"European Action on anticoagulation. The prothrombin time \/international normalized ratio (PT\/INR) Line: derivation\u00a0of local INR with commercial thromboplastins and coagulometers \u2013 two independent studies","volume":"9","author":"Poller","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12590_bb0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1309\/AJCPEKRPL4K8TZMF","article-title":"Evaluation of European Concerted Action on Anticoagulation lyophilized plasmas for INR derivation using the PT\/INR Line","volume":"135","author":"Ibrahim","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/jth.12590_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2011.05.016","article-title":"Editorial: Local international normalised ratio (INR) derivation simplified using the European Concerted Action on Anticoagulation (ECAA) prothrombin time\/INR Line","volume":"128","author":"Poller","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12590_bb0045","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1538-7836.2012.04751.x","article-title":"Coagulometer international sensitivity index derivation, a rapid method using the prothrombin time\/international normalised ratio (PT\/INR) Line: a multicentre study","volume":"10","author":"Poller","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12590_bb0050","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jth.12322","article-title":"The clinical evaluation of INR variability and control in conventional oral anticoagulant administration using the variance growth rate","volume":"11","author":"Ibrahim","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12590_bb0055","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.2.5408.565","article-title":"Standardization of anticoagulant treatment: the Manchester regional thromboplastin scheme","volume":"2","author":"Poller","year":"1964","journal-title":"Br Med J"},{"key":"10.1111\/jth.12590_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(67)91109-9","article-title":"A national standard for anticoagulant therapy. The Manchester comparative reagent","volume":"1","author":"Poller","year":"1967","journal-title":"Lancet"},{"key":"10.1111\/jth.12590_bb0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2141.1994.tb03260.x","article-title":"The correction of coagulometer effects on international normalized ratios: a multicentre evaluation","volume":"86","author":"Poller","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12590_bb0070","series-title":"Oral Anticoagulants","first-page":"49","article-title":"Laboratory monitoring of anticoagulants","author":"Poller","year":"1996"},{"key":"10.1111\/jth.12590_bb0075","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/jclinpath-2011-200068","article-title":"INR derivation with the PT\/INR Line simplified using a spreadsheet from the world\u2010 wide web","volume":"64","author":"Poller","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.12590_bb0080","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1160\/TH13-06-0443","article-title":"Vitamin K antagonists in heart disease: current status and perspectives (section III)","volume":"110","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12590_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","article-title":"Risk factors for complications of chronic anticoagulation: a multicenter study","volume":"118","author":"Fihn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12590_bb0090","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12590","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12590","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622039794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12590\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:08:26Z","timestamp":1761534506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622039794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1538783622039794"],"URL":"https:\/\/doi.org\/10.1111\/jth.12590","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Warfarin or dabigatran for treatment of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}